HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Latent TGF-beta1 protects against crescentic glomerulonephritis.

Abstract
Despite the critical role that TGF-beta plays in renal fibrosis, transgenic mice that overexpress human latent TGF-beta1 in the skin exhibit normal renal histology and function even though circulating levels of latent TGF-beta1 are an order of magnitude higher than wild-type animals. In fact, latent TGF-beta1 seems to protect against renal inflammation in a model of ureteral obstruction. It is unknown, however, whether latent TGF-beta1 also has this effect in immunologically mediated forms of renal disease such as anti-GBM crescentic glomerulonephritis. We induced anti-GBM disease in wild-type and transgenic mice overexpressing latent TGF-beta1 in keratinocytes. After 14 days, wild-type mice developed progressive crescentic glomerulonephritis with severe renal inflammation and fibrosis. In transgenic mice, proteinuria was reduced by 50%, renal function was preserved, and the formation of glomerular crescents was suppressed by 70%. In addition, transgenic animals had reduced renal inflammation, evidenced by a 70% decrease in the accumulation of T cells and macrophages, and reduced expression of renal IL-1beta, TNFalpha, and MCP-1 by 70 to 80%. Progressive renal fibrosis was also prevented in the transgenic mice, and these protective effects were associated with elevated levels of latent, but not active, TGF-beta1 in plasma and renal tissue. Renal Smad7 was up-regulated and both NF-kappaB and TGF-beta/Smad2/3 activation were suppressed. In conclusion, mice overexpressing latent TGF-beta1 in the skin were protected against anti-GBM crescentic glomerulonephritis, possibly via Smad 7-mediated inhibition of NF-kappaB-dependent renal inflammation and TGF-beta/Smad2/3-dependent fibrosis.
AuthorsXiao R Huang, Arthur C K Chung, Li Zhou, Xiao J Wang, Hui Y Lan
JournalJournal of the American Society of Nephrology : JASN (J Am Soc Nephrol) Vol. 19 Issue 2 Pg. 233-42 (Feb 2008) ISSN: 1533-3450 [Electronic] United States
PMID18216320 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Ccl2 protein, mouse
  • Chemokine CCL2
  • Smad2 Protein
  • Smad2 protein, mouse
  • Smad3 Protein
  • Smad3 protein, mouse
  • Smad7 Protein
  • Smad7 protein, mouse
  • Transcription Factor RelA
  • Transforming Growth Factor beta1
  • Tumor Necrosis Factor-alpha
  • Complement System Proteins
Topics
  • Animals
  • Chemokine CCL2 (metabolism)
  • Complement System Proteins (metabolism)
  • Disease Models, Animal
  • Fibrosis
  • Glomerular Basement Membrane (immunology, metabolism, pathology)
  • Glomerulonephritis (immunology, pathology, physiopathology)
  • Humans
  • Keratinocytes (physiology)
  • Macrophages (pathology)
  • Mice
  • Mice, Inbred ICR
  • Mice, Transgenic
  • Proteinuria (immunology, pathology, physiopathology)
  • Smad2 Protein (metabolism)
  • Smad3 Protein (metabolism)
  • Smad7 Protein (metabolism)
  • T-Lymphocytes (pathology)
  • Transcription Factor RelA (metabolism)
  • Transforming Growth Factor beta1 (genetics, immunology, metabolism)
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: